NSHSF (Nanosphere Health Sciences) FCF Yield %: -14.08 (As of Jun. 29, 2026)


What is Nanosphere Health Sciences FCF Yield %?

Nanosphere Health Sciences NSHSF FCF Yield % is -14.08 as of Jun. 29, 2026. Among 1,415 Biotechnology companies, Nanosphere Health Sciences ranks worse than 58.87% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nanosphere Health Sciences's Trailing 12-Month Free Cash Flow is $-0.02 Mil, and Market Cap is $0.15 Mil. Therefore, Nanosphere Health Sciences's FCF Yield % for today is -14.08%.

The historical rank and industry rank for Nanosphere Health Sciences's FCF Yield % or its related term are showing as below:

NSHSF' s FCF Yield % Range Over the Past 10 Years
Min: -745.66   Med: -47.15   Max: 3.28
Current: -14.08


During the past 13 years, the highest FCF Yield % of Nanosphere Health Sciences was 3.28%. The lowest was -745.66%. And the median was -47.15%.

NSHSF's FCF Yield % is ranked worse than
58.87% of 1415 companies
in the Biotechnology industry
Industry Median: -9.62 vs NSHSF: -14.08

Nanosphere Health Sciences's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.


Nanosphere Health Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nanosphere Health Sciences FCF Yield % Related Terms


Nanosphere Health Sciences FCF Yield % Historical Data

* Premium members only.

The historical data trend for Nanosphere Health Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosphere Health Sciences FCF Yield % Chart

Nanosphere Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.14 -60.16 -210.22 -12.51 -16.96

Nanosphere Health Sciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.86 50.61 225.38 -126.52 -94.37

NSHSF vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Nanosphere Health Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's FCF Yield % falls into.



Nanosphere Health Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nanosphere Health Sciences's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.023 / 0.13563
=-16.96%

Nanosphere Health Sciences's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.032 * 4 / 0.13563
=-94.37%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -14.08 mean?
Nanosphere Health Sciences (NSHSF) has a FCF Yield % of -14.08 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nanosphere Health Sciences and its competitors. According to the industry distribution chart, Nanosphere Health Sciences ranks #833 out of 1415 companies in the Biotechnology industry, placing it in the top 58.9%.
Is Nanosphere Health Sciences' FCF Yield % too high?
Nanosphere Health Sciences' current FCF Yield % is -14.08. Based on the distribution chart, Nanosphere Health Sciences ranks #833 out of 1415 companies in the Biotechnology industry, which is below the industry midpoint.
How does Nanosphere Health Sciences' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanosphere Health Sciences ranks #833 out of 1415 companies for FCF Yield %. This places Nanosphere Health Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nanosphere Health Sciences and its competitors. Nanosphere Health Sciences's current FCF Yield % is -14.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosphere Health Sciences stock overvalued right now?
Nanosphere Health Sciences (NSHSF) has a current FCF Yield % of -14.08. The current FCF Yield % is -14.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Nanosphere Health Sciences (NSHSF), the current FCF Yield % is -14.08 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanosphere Health Sciences Business Description

Other Exchanges 2CG:GermanyNSHS:Canada
Address 605 Robson Street, c/o Suite 430, Vancouver, BC, CAN, V6B 5J3
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.